Resorbable (Bioresorbable) Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Agro-Polymers, Biopolyesters, Others), By Application (Orthopedics, Cardiac Implants, Dental Implants, Oral Drug Delivery, Others), By Region and Competition, 2020-2030F

Market Overview

Global Resorbable (Bioresorbable) Polymers Market was valued at USD 460.80 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 4.90% through 2030. Bioresorbable polymers, a groundbreaking technological advancement in the field of materials, offer a unique characteristic of being broken down by the body without requiring mechanical removal, such as sutures or the chlorhexidine chip. These bioresorbable materials find applications in a wide range of medical indications, including sutures, coronary and peripheral vascular scaffolds, tissue fixation screws, bone pins and anchors, drug delivery coatings, as well as microspheres, surgical meshes, and matrices. The materials in this category encompass polymers, metals, ceramics, glasses, and even materials of biological origin like natural collagen, which not only allow for drug elution and delivery but also serve mechanical functions. Currently, the bioresorbable market is in its developing stage, although bioresorbable sutures have been available for over 40 years. Recent innovations have expanded the market to encompass cardiovascular, orthopedic, and general surgery. Looking ahead, the global bioresorbable market is anticipated to witness substantial growth, driven by the increasing demand from major applications such as orthopedics and drug delivery. Factors contributing to the growth of the bioresorbable market include patient-friendliness, the rising demand for drugs and medicines, the growing number of surgeries, and the increasing awareness among people. However, it is important to note that technological sophistication resulting in higher costs may pose a challenge and restrain the growth of the market.

Key Market Drivers

Rising Demand for Biodegradable and Biocompatible Materials in Healthcare 

The increasing demand for biodegradable and biocompatible materials in healthcare is a primary factor driving the growth of the global resorbable (bioresorbable) polymers market. As the medical industry shifts towards patient-centric, minimally invasive, and sustainable solutions, bioresorbable polymers are emerging as an essential material class due to their ability to degrade naturally in the body without requiring surgical removal. Traditional medical implants made from metals or permanent synthetic polymers often require secondary surgeries for removal, which increases patient risk, healthcare costs, and recovery time. In contrast, bioresorbable polymers naturally degrade within the body after fulfilling their intended function, eliminating the need for additional procedures.  Orthopedic implants, where bioresorbable screws, pins, and plates provide temporary structural support and gradually dissolve as bones heal. Osteoarthritis predominantly impacts individuals aged 55 and older, who account for 73% of cases, with women representing 60% of those affected (1). The condition most commonly affects the knee, with 365 million cases globally, followed by the hip and hand (2). Of these, 344 million people experience moderate to severe symptoms, indicating a significant population that could benefit from targeted rehabilitation interventions. These figures underscore the growing need for effective solutions to address the burden of osteoarthritis, particularly in aging demographics. Cardiovascular stents, which reduce long-term complications by dissolving once arteries regain functionality. In 2022, the global prevalence of coronary artery disease (CAD) was estimated at 315 million cases, with a 95% uncertainty range of 273 million to 362 million. The age-standardized prevalence rate stood at 3,605 cases per 100,000 people (uncertainty interval: 2,892 to 4,454 per 100,000), reflecting an 18% decline from 1990, when the rate was 4,390 per 100,000 (uncertainty interval: 3,510 to 5,445 per 100,000). Regional disparities were significant. Central Europe, Eastern Europe, and Central Asia recorded the highest age-standardized prevalence in 2022, reaching 8,019 cases per 100,000 (uncertainty interval: 6,530 to 9,719 per 100,000). In contrast, South Asia reported the lowest prevalence, at 2,393 cases per 100,000 (uncertainty interval: 1,746 to 3,188 per 100,000).  Soft tissue regeneration, where bioresorbable scaffolds promote cell growth and eventually disappear as new tissue forms. The growing preference for temporary, biodegradable implants is a major driver of market growth, as healthcare providers and patients seek safer, more efficient treatment options.

Bioresorbable sutures and meshes are becoming standard in wound closure and surgical applications due to their ability to: Minimize infection risks, as they dissolve naturally and do not require removal. Enhance healing, as they degrade at a controlled rate, reducing tissue damage. Improve patient comfort, eliminating the discomfort of suture removal. The increasing volume of surgeries worldwide—driven by aging populations, chronic diseases, and trauma cases—is further propelling demand for bioabsorbable wound closure products. Pharmaceutical companies are increasingly utilizing bioresorbable polymers in controlled and targeted drug delivery systems. These materials offer several advantages: Sustained drug release, ensuring consistent medication levels over time. Reduced side effects, as localized delivery minimizes systemic exposure. Personalized treatment options, with customizable degradation rates for specific medical needs. Implantable drug delivery systems for chemotherapy, which release drugs at a controlled pace and dissolve after treatment. Microspheres and nanoparticles for long-acting injectable medications in cancer and chronic disease management. Bioresorbable coatings on medical devices, enhancing their therapeutic effectiveness. The push towards precision medicine and advanced drug delivery technologies is significantly boosting demand for bioresorbable polymers.

Rising Demand for Sustainable and Eco-Friendly Alternatives

The growing emphasis on sustainability and eco-friendly materials is a significant factor fueling the expansion of the global resorbable (bioresorbable) polymers market. As industries across the world face increasing regulatory pressure, environmental concerns, and consumer demand for biodegradable solutions, the adoption of bioresorbable polymers is rising across multiple sectors. These polymers, which naturally degrade into non-toxic byproducts, offer a sustainable alternative to conventional plastics and synthetic materials, particularly in healthcare, pharmaceuticals, packaging, and agriculture.

This market trend is being driven by a combination of regulatory policies, corporate sustainability initiatives, and advancements in green technology, positioning bioresorbable polymers as a key component in the shift toward a more sustainable global economy. Governments and regulatory bodies worldwide are implementing stringent environmental policies to reduce plastic waste, prompting industries to seek biodegradable alternatives. In 2022, 74% of adults worldwide were aware of the United Nations Sustainable Development Goals (SDGs). However, awareness levels varied significantly by region. Great Britain and Japan had the lowest familiarity rates, with 51% of respondents unaware of the SDGs. Similarly, in the United States, 50% of adults had never heard of the initiative. In contrast, Turkey reported significantly higher awareness, with 92% of respondents familiar with the SDGs. Bans and restrictions on single-use plastics in multiple regions, including the EU’s Single-Use Plastics Directive and similar policies in the United States, Canada, and Asia-Pacific nations, are encouraging companies to adopt biodegradable polymers. Regulatory approvals for bioresorbable medical materials, such as those from the FDA (Food and Drug Administration) and EMA (European Medicines Agency), are facilitating their increased use in healthcare and pharmaceutical applications. Sustainability certifications and eco-labeling are driving businesses to adopt materials that align with environmental standards. With a rising emphasis on carbon footprint reduction and waste minimization, companies across industries are actively integrating bioresorbable polymers into their products and processes.

The medical industry is under increasing pressure to reduce medical waste, particularly from non-degradable plastics used in implants, sutures, drug delivery systems, and disposable medical devices. Reducing the environmental impact of medical waste, as they break down naturally over time. Eliminating the need for secondary surgeries to remove implants, reducing hospital waste and costs. Providing biocompatible and patient-friendly materials, which degrade safely within the body. Hospitals, research institutions, and healthcare providers are actively seeking sustainable solutions that align with global environmental goals, further driving demand for bioresorbable materials.

The packaging sector is witnessing a paradigm shift toward biodegradable materials, with bioresorbable polymers emerging as a promising alternative to traditional plastic packaging. By 2025, PepsiCo anticipate that 98% of our packaging will be designed to be recyclable, compostable, biodegradable, or reusable (RCBR). Additionally, 92% of our total packaging is projected to be both designed for RCBR and practically RCBR, considering the availability of end-of-life processing solutions. While this forecast falls short of our 100% target, we remain committed to driving innovation, making strategic investments, and forging key partnerships to further advance our sustainability efforts. Consumer demand for eco-friendly packaging, influencing purchasing behavior and brand loyalty. Advancements in bio-based polymer technology, making biodegradable packaging more durable and cost-effective. While healthcare remains the dominant sector for bioresorbable polymers, their increasing use in biodegradable food packaging, agricultural films, and disposable consumer goods is expanding market opportunities.

Download Free Sample Report

Key Market Challenges

Complexities Associated with Biocompatibility and Safety

Bioresorbable polymers are highly regarded for their exceptional biocompatibility, which enables them to be safely absorbed by the body once their purpose is fulfilled. This outstanding quality makes them ideal for a wide range of applications in the medical field, including medical devices and drug delivery systems, as well as various biomedical applications.

However, achieving the desired level of biocompatibility is a complex and intricate process. While synthetic polymers can help avoid issues with immunogenicity, they can introduce new challenges in ensuring biocompatibility. Thus, the development of bioresorbable polymers requires a delicate balance to ensure that these materials interact with the body without causing any adverse reactions.

In addition to biocompatibility, safety is another crucial aspect when it comes to bioresorbable polymers. Scientific evaluations have indicated that these polymers are generally safe for use in medical devices. However, their safety profile primarily depends on their design and how they degrade within the body. It is crucial that the degradation process of bioresorbable polymers is both predictable and safe, without causing any harm to the body. This necessitates rigorous testing and stringent quality control measures, adding yet another layer of complexity to the development and production of these materials.

Undoubtedly, the complexities associated with biocompatibility and safety pose significant challenges for the resorbable polymers market. These challenges can impede product development, elevate costs, and create barriers to market entry. Nonetheless, these complexities also serve as drivers for innovation within the market. They compel companies to invest in extensive research and development efforts, leading to the creation of advanced bioresorbable polymers with improved biocompatibility and enhanced safety profiles. By addressing these challenges head-on, the industry can pave the way for groundbreaking advancements in the field of bioresorbable polymers.

Key Market Trends

Growing Focus on Tissue Engineering

Tissue engineering, a highly interdisciplinary field, aims to develop functional tissues to restore, maintain, or enhance damaged tissues or whole organs. It involves the use of resorbable polymers as scaffolds, providing a three-dimensional structure for the growth of new tissue. These polymers, known for their biocompatibility and ability to safely degrade within the body, are ideal for tissue engineering applications.

The rising focus on regenerative medicine and tissue engineering is driving the demand for resorbable polymers. This growing trend has significant implications for the resorbable polymers market. Firstly, it leads to an increased demand for these materials, contributing to market growth. The application of resorbable polymers in tissue engineering is expected to continue expanding, further fueling the demand.

Moreover, this trend also spurs innovation in the market. With the increasing use of polymers in tissue engineering, companies are motivated to develop advanced bioresorbable polymers with improved properties, such as enhanced strength and flexibility. This drive for innovation pushes the boundaries of what is possible in tissue engineering.

Furthermore, the emphasis on tissue engineering encourages extensive research and development efforts in the field of resorbable polymers. This results in ongoing product developments and a significant increase in investment in research and development activities. Scientists and engineers strive to optimize the properties and performance of resorbable polymers, paving the way for breakthroughs in tissue engineering applications.

In conclusion, the growing focus on tissue engineering represents a significant and transformative trend in the global resorbable polymers market. As the field of tissue engineering continues to evolve and expand, the role of resorbable polymers in this field is set to become increasingly important, positively impacting the market's growth. The continuous advancements in resorbable polymers hold tremendous potential for revolutionizing regenerative medicine and improving patients' lives.

Segmental Insights

Application Insights

Based on category of Application, The orthopedics segment was emerging as the fastest-growing category in the global resorbable (bioresorbable) polymers market, driven by advancements in biodegradable implants, bone scaffolds, and fixation devices. As the healthcare industry shifts towards minimally invasive procedures, patient-friendly materials, and long-term biocompatibility, bioresorbable polymers are gaining widespread adoption in orthopedic applications. The growing preference for temporary yet durable solutions that naturally degrade in the body without requiring secondary surgical removal is further accelerating market demand.

Traditionally, metal implants have been widely used in fracture fixation, joint reconstruction, and ligament repair. Eliminate the need for secondary surgeries to remove hardware, reducing patient discomfort and healthcare costs. Support natural bone healing by gradually transferring load stress to the bone as the implant degrades. Minimize long-term complications, such as implant migration, corrosion, or chronic inflammation associated with permanent materials. Screws, pins, and plates for fracture stabilization. Sutures and anchors for ligament and tendon repair. Bone graft substitutes and scaffolds for guided tissue regeneration. These advantages are fueling increased demand, particularly in trauma and sports medicine, where bioresorbable fixation systems are transforming post-surgical recovery and rehabilitation. The development of next-generation bioresorbable polymers, such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), and poly(L-lactic acid) (PLLA), has significantly improved the mechanical strength, degradation rate, and biocompatibility of orthopedic implants. Customizable degradation profiles, ensuring implants remain functional during critical healing phases before resorption. Enhanced mechanical properties, allowing for greater load-bearing applications. Composite polymer blends, improving both strength and controlled bioabsorption. These material advancements are expanding the range of orthopedic procedures that can benefit from resorbable implants, positioning them as a preferred alternative to traditional metallic implants

Download Free Sample Report

Regional Insights

Based on region, North America emerged as largest market in the Global Resorbable (Bioresorbable) Polymers Market in 2024, holding the largest market share in terms of value. North America is home to major medical device and biotechnology companies that are actively developing and commercializing bioresorbable implants, sutures, drug delivery systems, and scaffolds. Companies such as Boston Scientific, Evonik, Stryker, and Medtronic are investing heavily in R&D and product innovation, accelerating market growth.

High research funding and innovation in biodegradable medical materials have led to the introduction of next-generation bioresorbable polymers with improved biocompatibility, mechanical strength, and controlled degradation rates. Academic and industry collaborations with institutions like Harvard, MIT, and the Mayo Clinic support continuous advancements in tissue engineering, regenerative medicine, and biodegradable implants. North America has one of the highest rates of orthopedic and cardiovascular diseases, driving the adoption of bioresorbable implants in fracture fixation, joint reconstruction, and cardiovascular stenting. A rise in sports injuries, bone fractures, and degenerative bone diseases has fueled demand for bioresorbable screws, plates, and scaffolds in trauma and reconstructive surgeries. The FDA approval of bioresorbable stents, such as those developed by Boston Scientific, has reinforced North America's market dominance in resorbable cardiovascular implants. With aging populations and increasing surgical procedures, the demand for biodegradable implants and fixation devices continues to expand.

Recent Developments

• In November 2024, From medical blister packaging to body implants, plastics play a critical role in the healthcare industry. Increasingly, bioplastics are being explored as viable alternatives for medical tools and devices, offering both functional and environmental benefits. Recognized for their biocompatibility, biodegradability, and reduced reliance on fossil-based materials, these innovative polymers are gaining traction across various medical applications.
• In May 2023, MANNHEIM, Germany, and PARIS, France – Serial coronary imaging of patients implanted with the Dreams 3G resorbable magnesium scaffold (Biotronik) for coronary artery disease has demonstrated favorable vessel healing, as indicated by changes in plaque composition. Findings from the BIOMAG-1 study, a focused clinical investigation, were presented at the European Atherosclerosis Society (EAS) Congress 2023, highlighting the scaffold’s potential in vascular restoration therapy.
• In March 2023, Evonik, a leading medical materials company, has partnered with BellaSeno, a specialist in 3D-printed absorbable scaffolds, to bring 3D-printed bone scaffolds to market for large and complex bone defects. These scaffolds are manufactured using Evonik’s Resomer® polymers, which are known for their biocompatibility and controlled resorption properties. The collaboration between the two companies began in 2019, initially focusing on scaffolds for chest wall and breast reconstruction. With this latest initiative, they aim to advance bone regeneration technologies and expand the clinical applications of resorbable 3D-printed implants.
• In February 2020, Evonik, a leading specialty chemicals company, introduced a groundbreaking bioresorbable polymer called RESOMER PrintPowder. This innovative polymer is the first of its kind and has been specifically designed to enable the 3D printing of complex bioresorbable medical devices, revolutionizing the field of medical technology.
• Fast forward to December 2020, and Evonik made yet another significant announcement. The company revealed its strategic plans to acquire the highly regarded LACTEL® business from DURECT Corporation, a renowned provider of biodegradable polymers. This strategic move, valued at USD 15 Million, showcases Evonik's dedication to expanding its portfolio and strengthening its position in the biodegradable polymers market.

Key Market Players

• Corbion NV
• Poly-Med, Inc.
• Foster Corporation
• Evonik Industries AG
• KLS-Martin Limited
• 3d Biotek LLC
• Degradable solutions AG
• Koninklijke DSM N.V.
• FUTERRO S.A.
• Abbott Laboratories Inc

Report Scope:

In this report, the Global Resorbable (Bioresorbable) Polymers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Resorbable (Bioresorbable) Polymers Market, By Type:

o   Agro-Polymers

o   Biopolyesters

o   Others

• Resorbable (Bioresorbable) Polymers Market, By Application:

o   Orthopedics

o   Cardiac Implants

o   Dental Implants

o   Oral Drug Delivery

o   Others

• Resorbable (Bioresorbable) Polymers Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Resorbable (Bioresorbable) Polymers Market.

Available Customizations:

Global Resorbable (Bioresorbable) Polymers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Resorbable (Bioresorbable) Polymers Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com